We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.6B
AUM Growth
+$1.7B
Cap. Flow
+$117M
Cap. Flow %
0.24%
Top 10 Hldgs %
16.96%
Holding
3,019
New
199
Increased
1,870
Reduced
823
Closed
112

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$61.6M
2
MSFT icon
Microsoft
MSFT
+$29.1M
3
EVRG icon
Evergy
EVRG
+$26.2M
4
AMZN icon
Amazon
AMZN
+$25.8M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$20.2M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$130M
2
MON
Monsanto Co
MON
+$88.9M
3
AAPL icon
Apple
AAPL
+$21.2M
4
KDP icon
Keurig Dr Pepper
KDP
+$18.4M
5
GILD icon
Gilead Sciences
GILD
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 17.45%
2 Financials 16.24%
3 Healthcare 13.05%
4 Consumer Discretionary 10.25%
5 Industrials 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMH
2876
DELISTED
Impac Mortgage Holdings Inc.
IMH
$95K ﹤0.01%
+10,001
New +$89.4K
FCEL icon
2877
FuelCell Energy
FCEL
$1.73B
$94K ﹤0.01%
+197
New +$129K
BW icon
2878
Babcock & Wilcox
BW
$1.39B
$92K ﹤0.01%
3,856
-3,252
-46% -$86.4K
OVID icon
2879
Ovid Therapeutics
OVID
$414M
$92K ﹤0.01%
+11,816
New +$101K
MARK
2880
DELISTED
Remark Holdings, Inc.
MARK
$92K ﹤0.01%
+2,345
New +$128K
SHLD
2881
DELISTED
Sears Holding Corporation
SHLD
$91K ﹤0.01%
38,575
+24,180
+168% +$70.8K
FNM
2882
DELISTED
FANNIE MAE
FNM
$90K ﹤0.01%
63,500
CELH icon
2883
Celsius Holdings
CELH
$7.47B
$89K ﹤0.01%
+58,305
New +$94.9K
IBRX icon
2884
ImmunityBio
IBRX
$7.51B
$87K ﹤0.01%
28,522
+44
+0.2% +$163
MBII
2885
DELISTED
Marrone Bio Innovations, Inc.
MBII
$87K ﹤0.01%
+47,127
New +$87.7K
SCTL
2886
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$84K ﹤0.01%
18,736
+4,693
+33% +$37.2K
MFIC icon
2887
MidCap Financial Investment
MFIC
$787M
$78K ﹤0.01%
4,676
SAN icon
2888
Banco Santander
SAN
$201B
$77K ﹤0.01%
15,014
FLNT
2889
Fluent
FLNT
$102M
$74K ﹤0.01%
5,026
+1,973
+65% +$32.2K
FSK icon
2890
FS KKR Capital
FSK
$2.96B
$74K ﹤0.01%
+2,534
New +$77.3K
MFG icon
2891
Mizuho Financial
MFG
$127B
$74K ﹤0.01%
21,686
FSNN
2892
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$73K ﹤0.01%
+18,415
New +$84K
ADMA icon
2893
ADMA Biologics
ADMA
$1.96B
$72K ﹤0.01%
+16,060
New +$80K
LVO icon
2894
LiveOne
LVO
$61.7M
$71K ﹤0.01%
+1,233
New +$60.6K
ZOM
2895
DELISTED
Zomedica Corp.
ZOM
$71K ﹤0.01%
+31,685
New +$63.6K
MUFG icon
2896
Mitsubishi UFJ Financial
MUFG
$253B
$67K ﹤0.01%
11,805
PFIE
2897
DELISTED
Profire Energy, Inc
PFIE
$66K ﹤0.01%
+19,545
New +$78.9K
NH
2898
DELISTED
NantHealth, Inc
NH
$65K ﹤0.01%
1,304
+310
+31% +$15.3K
KODK icon
2899
Kodak
KODK
$822M
$64K ﹤0.01%
16,776
+1,763
+12% +$8.93K
NMR icon
2900
Nomura Holdings
NMR
$28.3B
$64K ﹤0.01%
13,349
+334
+3% +$1.82K

Similar funds

RhumbLine Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, RhumbLine Advisers held 3,019 positions worth $49.6B, up 3.6% from $47.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

RhumbLine Advisers's Q2 2018 filing shows 199 new, 1,870 increased, 823 reduced and 112 closed positions. Its largest new stake was Evergy: 490,078 shares worth $27.5M. The largest sale was Time Warner Inc, an estimated $130M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2018 buy was Evergy: 490,078 shares worth $27.5M.
  • RhumbLine Advisers added most to AT&T in Q2 2018, an estimated $61.6M increase.
  • RhumbLine Advisers's biggest Q2 2018 reduction was Apple, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited Time Warner Inc in Q2 2018, selling an estimated $130M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $49.6B portfolio in Q2 2018.
  • RhumbLine Advisers opened 199 new positions and closed 112 in Q2 2018.
  • RhumbLine Advisers's portfolio value rose 3.6% quarter-over-quarter to $49.6B.

Based on RhumbLine Advisers's 13F filing for Q2 2018, filed 6 Aug 2018.